Why did Honeywell's Q4 adjusted EPS decline despite beating guidance?

Adjusted EPS fell 8% to $2.47 mainly because of the $0.45 per share impact from the Bombardier agreement, which is a strategic deal with an upfront earnings hit. Excluding that impact, adjusted EPS grew 9%. Q4 results also reflected cost inflation and mix pressure in Aerospace original equipment, along with prior-year license and settlement payments and write-downs in Industrial Automation.

What is the planned separation, and when will it happen?

Honeywell intends to separate its Automation and Aerospace Technologies businesses in a tax-free transaction for shareholders, targeted for the second half of 2026. Together with the Advanced Materials spin-off (expected by end-2025 or early 2026), this would create three independent, publicly listed companies. Honeywell Automation would have about $18B of 2024 revenue, Honeywell Aerospace about $15B, and Advanced Materials nearly $4B. The transaction remains subject to Form 10 filing, tax confirmation, regulatory approvals, and final board approval.

What does the 2025 guidance imply for growth and profitability?

Management expects 2025 sales of $39.6-40.6B and organic growth of 2-5%, with adjusted EPS of $10.10-10.50, up 2-6%. Excluding Bombardier, organic growth is 1-4% and adjusted EPS is roughly flat to up 2%. Segment margin is expected to expand 60-100 bps (23.2-23.6%) on a reported basis, but the ex-Bombardier margin change is guided down 10 to up 30 bps. The guidance assumes a mid-year close of the Personal Protective Equipment divestiture.

How strong is Honeywell's cash generation and balance sheet capacity after the acquisitions?

Full-year operating cash flow reached $6.1B and free cash flow $4.9B, both up year over year and at the high end of guidance. Honeywell deployed $14.6B of capital in 2024, primarily for $8.9B of acquisitions, funded in part by debt. Long-term debt rose to $25.5B from $16.6B, and commercial paper increased to $4.3B. Management said Honeywell Automation and Aerospace are each expected to maintain strong investment-grade ratings, and the company is on pace to deploy at least $25B through 2025.

What are the main risks behind the strong backlog and growth outlook?

The record $35.3B backlog supports multi-year revenue visibility, but Industrial Automation remains weak, with organic sales flat in Q4 and segment profit down 10%. Aerospace margins compressed significantly in Q4, and Bombardier dilutes near-term earnings. Separation execution, one-time separation costs, and macroeconomic and geopolitical risks, including supply chain disruptions and inflation, could affect the timing and value of the planned transactions.

HON 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed February 6, 2025. Cited figures are marked; the original filing is the authoritative source.

Honeywell (HON) reported fourth-quarter and full-year 2024 results that met or exceeded its updated guidance, and issued 2025 guidance.

Q4 sales were $10.1 billion^a, up 7% reported but only 2% organically (6% excluding the Bombardier agreement impact). Adjusted EPS was $2.47, down 8% year over year, though it beat previous guidance; excluding the $0.45 Bombardier impact, it rose 9%. Segment margin contracted 350 basis points to 20.9% (70 basis points to 23.7% excluding Bombardier).

Full-year sales rose 5% to $38.5 billion^b, with 3% organic growth, and adjusted EPS grew 4% to $9.89. Free cash flow was $4.9 billion, at the high end of prior guidance. Backlog reached a record $35.3 billion, and the company deployed a record $14.6 billion of capital in 2024, including $8.9 billion on acquisitions.

For 2025, management guides to sales of $39.6^c-40.6 billion, organic growth of 2-5%, adjusted EPS of $10.10-10.50 (up 2-6%), and free cash flow of $5.4-5.8 billion. Excluding Bombardier, the company expects organic growth of 1-4% and adjusted EPS roughly flat to up 2% (down 2% to up 2%). The guidance assumes a mid-year close of the sale of the Personal Protective Equipment business.

The most significant strategic development is the Board's decision to pursue a full, tax-free separation of Automation and Aerospace Technologies, targeted for the second half of 2026. Combined with the previously announced spin-off of Advanced Materials (expected by end-2025 or early 2026), this would create three standalone public companies. Investors should weigh the potential for value unlocking against execution risk, separation costs (already visible as divestiture-related charges), and the outlook for Bombardier-related dilution in 2025.

02—Key points

Key Highlights

Q4 2024 sales of $10.1B rose 7% reported but only 2% organically; Bombardier agreement reduced Q4 sales by about $0.4B and net income by about $0.3B.
Q4 adjusted EPS of $2.47 fell 8% year over year but beat prior guidance; excluding the $0.45 Bombardier impact, it rose 9%.
Q4 segment margin contracted 350 bps to 20.9%, while Aerospace Technologies margin fell 780 bps to 20.3% and Industrial Automation fell 200 bps to 19.6%.
Full-year 2024 operating cash flow of $6.1B (up 14%) and free cash flow of $4.9B (up 15%), at the high end of guidance; record $14.6B capital deployed, including $8.9B in acquisitions.
2025 guidance: sales of $39.6-40.6B, organic growth of 2-5%, adjusted EPS of $10.10-10.50, and free cash flow of $5.4-5.8B.
Board approved a full tax-free separation of Automation and Aerospace Technologies, targeted for 2H 2026, creating three public companies alongside the Advanced Materials spin.
Record backlog of $35.3B, up 11%, supports visibility into 2025 and beyond, particularly in Aerospace defense and commercial aftermarket.

03—Questions

Frequently Asked Questions

Why did Honeywell's Q4 adjusted EPS decline despite beating guidance?
Adjusted EPS fell 8% to $2.47 mainly because of the $0.45 per share impact from the Bombardier agreement, which is a strategic deal with an upfront earnings hit. Excluding that impact, adjusted EPS grew 9%. Q4 results also reflected cost inflation and mix pressure in Aerospace original equipment, along with prior-year license and settlement payments and write-downs in Industrial Automation.
What is the planned separation, and when will it happen?
Honeywell intends to separate its Automation and Aerospace Technologies businesses in a tax-free transaction for shareholders, targeted for the second half of 2026. Together with the Advanced Materials spin-off (expected by end-2025 or early 2026), this would create three independent, publicly listed companies. Honeywell Automation would have about $18B of 2024 revenue, Honeywell Aerospace about $15B, and Advanced Materials nearly $4B. The transaction remains subject to Form 10 filing, tax confirmation, regulatory approvals, and final board approval.
What does the 2025 guidance imply for growth and profitability?
Management expects 2025 sales of $39.6-40.6B and organic growth of 2-5%, with adjusted EPS of $10.10-10.50, up 2-6%. Excluding Bombardier, organic growth is 1-4% and adjusted EPS is roughly flat to up 2%. Segment margin is expected to expand 60-100 bps (23.2-23.6%) on a reported basis, but the ex-Bombardier margin change is guided down 10 to up 30 bps. The guidance assumes a mid-year close of the Personal Protective Equipment divestiture.
How strong is Honeywell's cash generation and balance sheet capacity after the acquisitions?
Full-year operating cash flow reached $6.1B and free cash flow $4.9B, both up year over year and at the high end of guidance. Honeywell deployed $14.6B of capital in 2024, primarily for $8.9B of acquisitions, funded in part by debt. Long-term debt rose to $25.5B from $16.6B, and commercial paper increased to $4.3B. Management said Honeywell Automation and Aerospace are each expected to maintain strong investment-grade ratings, and the company is on pace to deploy at least $25B through 2025.
What are the main risks behind the strong backlog and growth outlook?
The record $35.3B backlog supports multi-year revenue visibility, but Industrial Automation remains weak, with organic sales flat in Q4 and segment profit down 10%. Aerospace margins compressed significantly in Q4, and Bombardier dilutes near-term earnings. Separation execution, one-time separation costs, and macroeconomic and geopolitical risks, including supply chain disruptions and inflation, could affect the timing and value of the planned transactions.

04—Continue

← View all 8-K filings